0001104659-23-000080.txt : 20230103 0001104659-23-000080.hdr.sgml : 20230103 20230103070531 ACCESSION NUMBER: 0001104659-23-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221229 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAYDEN DONALD J JR CENTRAL INDEX KEY: 0001202285 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40869 FILM NUMBER: 23500178 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001745020 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830712806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 314 MAIN STREET, SUITE 04-200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (857) 400-9491 MAIL ADDRESS: STREET 1: 314 MAIN STREET, SUITE 04-200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 tm2233814-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-12-29 0 0001745020 Theseus Pharmaceuticals, Inc. THRX 0001202285 HAYDEN DONALD J JR C/O THESEUS PHARMACEUTICALS, INC. 314 MAIN STREET CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2022-12-29 4 P 0 100 5 A 100 D Common Stock 2022-12-30 4 P 0 9900 4.9989 A 10000 D The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $4.98 to $5.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. /s/ Bradford Dahms - Attorney-in-Fact 2023-01-03